TCIM
ANAC

TIAA CREF Investment Management’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

TIAA CREF Investment Management’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-178,668
Closed -$9.55M – 3298
2016
Q1 		$9.55M Sell
178,668
-10,507
-6% -$776K 0.01% 1079
2015
Q4 		$21.4M Sell
189,175
-20,299
-10% -$2.24M 0.02% 732
2015
Q3 		$24.7M Buy
209,474
+17,057
+9% +$2.23M 0.02% 673
2015
Q2 		$14.9M Buy
192,417
+39,346
+26% +$2.58M 0.01% 916
2015
Q1 		$8.86M Buy
153,071
+21,852
+17% +$928K 0.01% 1237
2014
Q4 		$4.23M Sell
131,219
-6,195
-5% -$186K ﹤0.01% 1741
2014
Q3 		$3.36M Sell
137,414
-4,507
-3% -$91.6K ﹤0.01% 1882
2014
Q2 		$2.52M Buy
141,921
+45,070
+47% +$726K ﹤0.01% 2160
2014
Q1 		$1.94M Hold
96,851
– – ﹤0.01% 2253
2013
Q4 		$1.63M Sell
96,851
-2,950
-3% -$40.8K ﹤0.01% 2371
2013
Q3 		$1.06M Buy
99,801
+5,428
+6% +$47.5K ﹤0.01% 2571
2013
Q2 		$528K Buy
+94,373
New +$571K ﹤0.01% 2918

Other funds holding ANAC

KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

TIAA CREF Investment Management's ANAC Position: Q2 2016 in Review

TIAA CREF Investment Management sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 178,668 shares — an estimated $9.55M sold.

TIAA CREF Investment Management first reported a position in ANAC in Q2 2013 and held it in 12 quarters. The position peaked at $24.7M in Q3 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

  • TIAA CREF Investment Management reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
  • TIAA CREF Investment Management sold 178,668 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $9.55M.
  • TIAA CREF Investment Management first reported a position in ANACOR PHARMACEUTICALS INC COM in Q2 2013 and held it in 12 quarters.
  • TIAA CREF Investment Management's ANACOR PHARMACEUTICALS INC COM position peaked at $24.7M in Q3 2015.
  • 2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on TIAA CREF Investment Management's 13F filing for Q2 2016, filed 11 Aug 2016.